Singh Gill Amrik, Morrissey Hana, Rahman Ayesha
School of Pharmacy, University of Wolverhampton, Wolverhampton WV1 1LY, UK.
Medicina (Kaunas). 2018 Dec 1;54(6):95. doi: 10.3390/medicina54060095.
The use of antibiotic prophylaxis in extraction and implant dentistry is still controversial, with varying opinions regarding their necessity. The overuse of antibiotics has led to widespread antimicrobial resistance and the emergence of multi drug resistant strains of bacteria. The main aim of this work was to determine whether there is a genuine need for antibiotic prophylaxis in two common dental procedures; dental implants and tooth extractions. Electronic searches were conducted across databases such as Cochrane Register of Controlled Trials, the UK National Health Service, Centre for reviews, Science Direct, PubMed and the British Dental Journal to identify clinical trials of either dental implants or tooth extractions, whereby the independent variable was systemic prophylactic antibiotics used as part of treatment in order to prevent postoperative complications such as implant failure or infection. Primary outcomes of interest were implant failure, and postoperative infections which include systemic bacteraemia and localised infections. The secondary outcome of interest was adverse events due to antibiotics. The Critical Appraisal Skills Programme tool was used to assess the risk of bias, extract outcomes of interest and to identify studies for inclusion in the meta-analysis. Seven randomised clinical trials (RCTs) were included in the final review comprising = 1368 patients requiring either tooth extraction(s) or dental implant(s). No statistically significant evidence was found to support the routine use of prophylactic antibiotics in reducing the risk of implant failure ( = 0.09, RR 0.43; 95% CI 0.16⁻1.14) or post-operative complications ( = 0.47, RR: 0.74; 95% CI 0.34⁻1.65) under normal conditions. Approximately 33 patients undergoing dental implant surgery need to receive antibiotics in order to prevent one implant failure from occurring. There is little conclusive evidence to suggest the routine use of antibiotic prophylaxis for third molar extractive surgery in healthy young adults. There was no statistical evidence for adverse events experienced for antibiotics vs. placebo. Based on our analysis, even if financially feasible, clinicians must carefully consider the appropriate use of antibiotics in dental implants and extraction procedures due to the risk of allergic reactions and the development of microbial drug resistance.
在拔牙和种植牙科中使用抗生素预防措施仍存在争议,对于其必要性存在不同观点。抗生素的过度使用已导致广泛的抗菌药物耐药性以及多重耐药菌株的出现。这项工作的主要目的是确定在两种常见的牙科手术(种植牙和拔牙)中是否真的需要抗生素预防。通过在Cochrane对照试验注册库、英国国家医疗服务体系、综述中心、科学Direct、PubMed和《英国牙科杂志》等数据库中进行电子检索,以识别种植牙或拔牙的临床试验,其中自变量是作为治疗一部分使用的全身性预防性抗生素,目的是预防术后并发症,如种植失败或感染。感兴趣的主要结局是种植失败以及术后感染,包括全身性菌血症和局部感染。感兴趣的次要结局是抗生素引起的不良事件。使用批判性评估技能计划工具来评估偏倚风险、提取感兴趣的结局并确定纳入荟萃分析的研究。最终综述纳入了7项随机临床试验(RCT),共1368例需要拔牙或种植牙的患者。未发现有统计学意义的证据支持在正常情况下常规使用预防性抗生素来降低种植失败风险(P = 0.09,RR 0.43;95% CI 0.16⁻1.14)或术后并发症风险(P = 0.47,RR:0.74;95% CI 0.34⁻1.65)。大约33例接受种植牙手术的患者需要接受抗生素治疗才能预防1例种植失败的发生。几乎没有确凿证据表明健康年轻成年人的第三磨牙拔除手术常规使用抗生素预防是必要的。没有统计学证据表明抗生素与安慰剂相比会出现不良事件。基于我们的分析,即使在经济上可行,由于存在过敏反应风险和微生物耐药性的发展,临床医生在种植牙和拔牙手术中必须谨慎考虑抗生素的恰当使用。